Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Patterns of Antipsychotic Prescribing by Physicians to Young Children.

Huskamp HA, Horvitz-Lennon M, Berndt ER, Normand ST, Donohue JM.

Psychiatr Serv. 2016 Dec 1;67(12):1307-1314. Epub 2016 Jul 15.

PMID:
27417891
2.

The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation.

Sholzberg M, Gomes T, Juurlink DN, Yao Z, Mamdani MM, Laupacis A.

PLoS One. 2016 Feb 25;11(2):e0149142. doi: 10.1371/journal.pone.0149142. eCollection 2016.

3.

The introduction of generic risperidone in Medicare Part D.

Fung V, Price M, Busch AB, Landrum MB, Fireman B, Nierenberg AA, Newhouse JP, Hsu J.

Am J Manag Care. 2016 Jan;22(1):41-8.

4.

ENTRY IN THE ADHD DRUGS MARKET: WELFARE IMPACT OF GENERICS AND ME-TOO'S.

Bokhari FA, Fournier GM.

J Ind Econ. 2013 Jun;61(2):339-392.

5.

Management of newer medications for attention-deficit/hyperactivity disorder in commercial health plans.

Hodgkin D, Horgan CM, Quinn AE, Merrick EL, Stewart MT, Leslie LK.

Clin Ther. 2014 Dec 1;36(12):2034-46. doi: 10.1016/j.clinthera.2014.09.019. Epub 2014 Nov 14.

6.

Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.

AbuDagga A, Stephenson JJ, Fu AC, Kwong WJ, Tan H, Weintraub WS.

BMC Health Serv Res. 2014 Jul 17;14:310. doi: 10.1186/1472-6963-14-310.

7.

Can increases in CHIP copayments reduce program expenditures on prescription drugs?

Sen B, Blackburn J, Morrisey M, Becker D, Kilgore M, Caldwell C, Menachemi N.

Medicare Medicaid Res Rev. 2014 May 20;4(2). pii: mmrr2014.004.02.a03. doi: 10.5600/mmrr2014-004-02-a03. eCollection 2014.

8.

Out-of-pocket medication costs and use of medications and health care services among children with asthma.

Karaca-Mandic P, Jena AB, Joyce GF, Goldman DP.

JAMA. 2012 Mar 28;307(12):1284-91. doi: 10.1001/jama.2012.340.

9.

How patient cost-sharing trends affect adherence and outcomes: a literature review.

Eaddy MT, Cook CL, O'Day K, Burch SP, Cantrell CR.

P T. 2012 Jan;37(1):45-55.

10.

Comparison of tiered formularies and reference pricing policies: a systematic review.

Morgan S, Hanley G, Greyson D.

Open Med. 2009;3(3):e131-9. Epub 2009 Aug 4.

11.

Systematic review on quality control for drug management programs: is quality reported in the literature?

Holtorf AP, McAdam-Marx C, Schaaf D, Eng B, Oderda G.

BMC Health Serv Res. 2009 Feb 25;9:38. doi: 10.1186/1472-6963-9-38. Review.

12.

Effects of a consumer driven health plan on pharmaceutical spending and utilization.

Parente ST, Feldman R, Chen S.

Health Serv Res. 2008 Oct;43(5 Pt 1):1542-56. doi: 10.1111/j.1475-6773.2008.00857.x. Epub 2008 May 13.

13.

What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.

Gemmill MC, Thomson S, Mossialos E.

Int J Equity Health. 2008 May 2;7:12. doi: 10.1186/1475-9276-7-12.

14.

Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007.

Lu CY, Ross-Degnan D, Soumerai SB, Pearson SA.

BMC Health Serv Res. 2008 Apr 7;8:75. doi: 10.1186/1472-6963-8-75.

15.

Effect of cost-sharing on use of asthma medication in children.

Ungar WJ, Kozyrskyj A, Paterson M, Ahmad F.

Arch Pediatr Adolesc Med. 2008 Feb;162(2):104-10. doi: 10.1001/archpediatrics.2007.21.

16.

Changes in how health plans provide behavioral health services.

Horgan CM, Garnick DW, Merrick EL, Hodgkin D.

J Behav Health Serv Res. 2009 Jan;36(1):11-24. Epub 2007 Sep 14.

17.

Supplemental Content

Support Center